{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Custom_Disease": [
        "COVID-19"
      ],
      "PublicationStatus": [
        "Preprint"
      ],
      "PublicationType": [
        "Editorial"
      ],
      "Section": [
        "Full Text"
      ]
    },
    "annotation_pattern": {},
    "annotation_url": {},
    "document_metadata": {
      "authors": "Thrishna",
      "contact": "thrishna@causalitybiomodels.com",
      "copyright": "Copyright © 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "COVID Knowledge Curation project",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "32187463.bel",
      "version": "2.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
      "MESH": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
      "PFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/pfam/pfam-names-20181024.belns",
      "TAX": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
    },
    "path": "32187463.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Editorial": true
        },
        "Section": {
          "Full Text": true
        }
      },
      "citation": {
        "authors": [
          "Baden LR",
          "Rubin EJ"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32187463",
        "db_name": "The New England journal of medicine",
        "first": "Baden LR",
        "last": "Rubin EJ"
      },
      "evidence": "One antiviral-drug candidate is a combination of the HIV protease inhibitors lopinavir and ritonavir.",
      "key": "edb6d03f470b9d4489573efa2426650b",
      "line": 44,
      "relation": "isA",
      "source": 6,
      "target": 1
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Editorial": true
        },
        "Section": {
          "Full Text": true
        }
      },
      "citation": {
        "authors": [
          "Baden LR",
          "Rubin EJ"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32187463",
        "db_name": "The New England journal of medicine",
        "first": "Baden LR",
        "last": "Rubin EJ"
      },
      "evidence": "The number of deaths was somewhat lower in the group that received lopinavir–ritonavir.",
      "key": "cbb40177f553450697eddd8ba9a7e05e",
      "line": 58,
      "relation": "decreases",
      "source": 6,
      "target": 4
    },
    {
      "key": "f18924ce25341d06b4bb377528fcb9a5",
      "relation": "partOf",
      "source": 2,
      "target": 6
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Editorial": true
        },
        "Section": {
          "Full Text": true
        }
      },
      "citation": {
        "authors": [
          "Baden LR",
          "Rubin EJ"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32187463",
        "db_name": "The New England journal of medicine",
        "first": "Baden LR",
        "last": "Rubin EJ"
      },
      "evidence": "One antiviral-drug candidate is a combination of the HIV protease inhibitors lopinavir and ritonavir.",
      "key": "fcbcd7196704521ea38d88d6c9480c94",
      "line": 45,
      "relation": "isA",
      "source": 2,
      "target": 0
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Editorial": true
        },
        "Section": {
          "Full Text": true
        }
      },
      "citation": {
        "authors": [
          "Baden LR",
          "Rubin EJ"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32187463",
        "db_name": "The New England journal of medicine",
        "first": "Baden LR",
        "last": "Rubin EJ"
      },
      "evidence": "Lopinavir, which acts against the viral 3CL protease, has modest antiviral activity against SARS-CoV-2.1",
      "key": "a41c8d221eff1ef7de2850d8c83580b9",
      "line": 51,
      "relation": "decreases",
      "source": 2,
      "target": 7
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Editorial": true
        },
        "Section": {
          "Full Text": true
        }
      },
      "citation": {
        "authors": [
          "Baden LR",
          "Rubin EJ"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32187463",
        "db_name": "The New England journal of medicine",
        "first": "Baden LR",
        "last": "Rubin EJ"
      },
      "evidence": "Lopinavir, which acts against the viral 3CL protease, has modest antiviral activity against SARS-CoV-2.1",
      "key": "072a7ea553d0a1678875ca37299b4a2b",
      "line": 52,
      "relation": "decreases",
      "source": 2,
      "target": 5
    },
    {
      "key": "6a69b9c011b905760ffd20c4fc045a23",
      "relation": "partOf",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Editorial": true
        },
        "Section": {
          "Full Text": true
        }
      },
      "citation": {
        "authors": [
          "Baden LR",
          "Rubin EJ"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32187463",
        "db_name": "The New England journal of medicine",
        "first": "Baden LR",
        "last": "Rubin EJ"
      },
      "evidence": "One antiviral-drug candidate is a combination of the HIV protease inhibitors lopinavir and ritonavir.",
      "key": "a4426e8f23663f8ac9a3b21c49b6e436",
      "line": 46,
      "relation": "isA",
      "source": 3,
      "target": 0
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"HIV protease inhibitor\")",
      "concept": {
        "name": "HIV protease inhibitor",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "37ed2f1b973cc1e2b29e997a3ac68cd8"
    },
    {
      "bel": "a(CHEBI:\"antiviral drug\")",
      "concept": {
        "name": "antiviral drug",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7d8331630891e7c2734e1db99c564d9f"
    },
    {
      "bel": "a(CHEBI:lopinavir)",
      "concept": {
        "name": "lopinavir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "540f0a29f78ff437222f25e1c2e1b0fd"
    },
    {
      "bel": "a(CHEBI:ritonavir)",
      "concept": {
        "name": "ritonavir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "07c1651afef7019b0cb107f1ce5fef12"
    },
    {
      "bel": "a(MESH:Mortality)",
      "concept": {
        "name": "Mortality",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "cf219a9c8a81a7e372e19173d071eef6"
    },
    {
      "bel": "a(TAX:\"Severe acute respiratory syndrome coronavirus 2\")",
      "concept": {
        "name": "Severe acute respiratory syndrome coronavirus 2",
        "namespace": "TAX"
      },
      "function": "Abundance",
      "id": "c41851da59cc36c21b2e8acf24c1f46d"
    },
    {
      "bel": "composite(a(CHEBI:lopinavir), a(CHEBI:ritonavir))",
      "function": "Composite",
      "id": "604986238aca313adcc37629dfa6e61a",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        }
      ]
    },
    {
      "bel": "p(PFAM:\"Peptidase_C30\")",
      "concept": {
        "name": "Peptidase_C30",
        "namespace": "PFAM"
      },
      "function": "Protein",
      "id": "5ee0fe4f2cc4209e0668ce55057efdd2"
    }
  ]
}